ADCK2 Antibody Blocking peptide
ADCK2 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Uncharacterized aarF domain-containing protein kinase 2, 2711-, ADCK2, AARF
UniProt
Q7Z695
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the Center region of human ADCK2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2256-12M-ML750 100 µL
CD5 (CD5 Antigen, CD5 Molecule, LEU1, Lymphocyte Antigen CD5, Lymphocyte Antigen T1/Leu 1, Lymphocyte Glycoprotein T1/Leu1, p56 62, T cell Surface Glycoprotein CD5, T1) (MaxLight 750) xxdiscontinued, see C2256-12M discontinued
Sign In for Pricing
View Details